E. V. Acosta-rodriguez and G. Napolitani, Interleukins 1?? and 6 but not transforming growth factor-?? are essential for the differentiation of interleukin 17???producing human T helper cells, Nature Immunology, vol.161, issue.9, pp.942-951, 2007.
DOI : 10.1084/jem.191.10.1777

E. V. Acosta-rodriguez and L. Rivino, Surface phenotype and antigenic specificity of human interleukin 17???producing T helper memory cells, Nature Immunology, vol.179, issue.6, pp.639-685, 2007.
DOI : 10.1038/ni1467

S. Adams and D. W. O-'neill, Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant, The Journal of Immunology, vol.181, issue.1, pp.776-84, 2008.
DOI : 10.4049/jimmunol.181.1.776

S. Amigorena and A. Savina, Intracellular mechanisms of antigen cross presentation in dendritic cells, Current Opinion in Immunology, vol.22, issue.1, pp.109-126, 2010.
DOI : 10.1016/j.coi.2010.01.022

F. Annunziato and L. Cosmi, Phenotypic and functional features of human Th17 cells, The Journal of Experimental Medicine, vol.162, issue.8, pp.1849-61, 2007.
DOI : 10.1634/stemcells.2005-0008

A. Aouba and F. Pequignot, Les causes médicales de décès en France en 2004 et leur évolution, pp.308-322, 1980.

C. Ardavin, Thymic dendritic cells, Immunology Today, vol.18, issue.7, pp.350-61, 1997.
DOI : 10.1016/S0167-5699(97)01090-6

C. Aspord and A. Pedroza-gonzalez, T cells that facilitate tumor development, The Journal of Experimental Medicine, vol.56, issue.5, pp.1037-1084, 2007.
DOI : 10.1038/ni872

C. Aspord and J. Charles, A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells, PLoS ONE, vol.5, issue.5, pp.5-10458, 2010.
DOI : 10.1371/journal.pone.0010458.s010

URL : https://hal.archives-ouvertes.fr/inserm-00484505

C. Asselin-paturel and A. Boonstra, Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology, Nature Immunology, vol.250, issue.12, pp.1144-50, 2001.
DOI : 10.1006/clim.2000.4858

M. B. Atkins and M. J. Robertson, Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies, Clin Cancer Res, vol.3, pp.409-426, 1997.

J. Banchereau and F. Briere, Immunobiology of Dendritic Cells, Annual Review of Immunology, vol.18, issue.1, pp.767-811, 2000.
DOI : 10.1146/annurev.immunol.18.1.767

J. Banchereau and J. Fay, Dendritic cells as melanoma vaccines, Dev BiolBasel), vol.116, pp.147-56, 2004.

J. Banchereau and A. K. Palucka, Dendritic cells as therapeutic vaccines against cancer, Nature Reviews Immunology, vol.10, issue.4, pp.296-306, 2005.
DOI : 10.1007/s00262-003-0429-0

G. Fedele and P. Stefanelli, Bordetella pertussis-Infected Human Monocyte-Derived Dendritic Cells Undergo Maturation and Induce Th1 Polarization and Interleukin-23 Expression, Infection and Immunity, vol.73, issue.3, pp.1590-1597, 2005.
DOI : 10.1128/IAI.73.3.1590-1597.2005

G. Gerlini and C. Urso, Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes, Clinical Immunology, vol.125, issue.2, pp.184-93, 2007.
DOI : 10.1016/j.clim.2007.07.018

M. Gilliet and Y. J. Liu, Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells, Human Immunology, vol.63, issue.12, pp.1149-55, 2002.
DOI : 10.1016/S0198-8859(02)00753-X

M. Gobert and I. Treilleux, Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome, Cancer Research, vol.69, issue.5, pp.2000-2009, 2009.
DOI : 10.1158/0008-5472.CAN-08-2360

R. C. Gray and J. Kuchtey, CpG-B ODNs potently induce low levels of IFN-???? and induce IFN-????-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs, Journal of Leukocyte Biology, vol.81, issue.4, pp.1075-85, 2007.
DOI : 10.1189/jlb.1006606

I. Gresser and C. Bourali, Antitumor effects of interferon preparations in mice, J Natl Cancer Inst, vol.45, pp.365-76, 1970.

G. Grouard and M. C. Rissoan, The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand, The Journal of Experimental Medicine, vol.153, issue.6, pp.1101-1112, 1997.
DOI : 10.1084/jem.185.2.341

M. Gu and P. M. Hine, Increased potency of BioThrax?? anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109, Vaccine, vol.25, issue.3, pp.526-560, 2007.
DOI : 10.1016/j.vaccine.2006.07.056

S. M. Haeryfar, The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation?, Trends in Immunology, vol.26, issue.6, pp.311-318, 2005.
DOI : 10.1016/j.it.2005.04.002

S. A. Halperin and S. Dobson, Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults, Vaccine, vol.24, issue.1, pp.20-26, 2006.
DOI : 10.1016/j.vaccine.2005.08.095

F. Heil and M. Hemmi, Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8, Science, vol.303, issue.5663, pp.1526-1535, 2004.
DOI : 10.1126/science.1093620

H. Hemmi and T. Kaisho, Small anti-viral compounds activate immune cells via the TLR7 MyD88???dependent signaling pathway, Nature Immunology, vol.3, issue.2, pp.196-200, 2002.
DOI : 10.1038/ni758

H. Hennings and A. B. Glick, Critical Aspects of Initiation, Promotion, and Progression in Multistage Epidermal Carcinogenesis, Experimental Biology and Medicine, vol.202, issue.1, pp.1-8, 1993.
DOI : 10.3181/00379727-202-43511A

M. Hernberg and S. Pyrhonen, Regimens With or Without Interferon-?? as Treatment for Metastatic Melanoma and Renal Cell Carcinoma: An Overview of Randomized Trials, Journal of Immunotherapy, vol.22, issue.2, pp.145-54, 1999.
DOI : 10.1097/00002371-199903000-00006

M. A. Hofmann and C. Kors, Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma, Journal of Immunotherapy, vol.31, issue.5, pp.520-527, 2008.
DOI : 10.1097/CJI.0b013e318174a4df

K. Hoshino and O. Takeuchi, Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product, J Immunol, vol.162, pp.3749-52, 1999.

A. Y. Huang and P. Golumbek, Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens, Science, vol.264, issue.5161, pp.961-966, 1994.
DOI : 10.1126/science.7513904

N. N. Hunder and H. Wallen, Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1, New England Journal of Medicine, vol.358, issue.25, pp.2698-703, 2008.
DOI : 10.1056/NEJMoa0800251

C. Infante-duarte and H. F. Horton, Microbial Lipopeptides Induce the Production of IL-17 in Th Cells, The Journal of Immunology, vol.165, issue.11, pp.6107-6122, 2000.
DOI : 10.4049/jimmunol.165.11.6107

J. R. Inglefield and C. D. Dumitru, TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN, Journal of Interferon & Cytokine Research, vol.28, issue.4, pp.253-63, 2008.
DOI : 10.1089/jir.2007.0097

F. Ishikawa and H. Niiro, The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways, Blood, vol.110, issue.10, pp.3591-660, 2007.
DOI : 10.1182/blood-2007-02-071613

T. Ito and R. Amakawa, Interferon-?? and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets, The Journal of Experimental Medicine, vol.163, issue.11, pp.1507-1519, 2002.
DOI : 10.1038/79747

T. Ito, Y. J. Liu, and N. Kadowaki, Functional Diversity and Plasticity of Human Dendritic Cell Subsets, International Journal of Hematology, vol.31, issue.3, pp.188-96, 2005.
DOI : 10.1532/IJH97.05012

T. Ito, Y. H. Wang, and Y. J. Liu, Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9, Springer Seminars in Immunopathology, vol.26, issue.3, pp.221-230, 2005.
DOI : 10.1007/s00281-004-0180-4

B. Jameson and F. Baribaud, Expression of DC-SIGN by Dendritic Cells of Intestinal and Genital Mucosae in Humans and Rhesus Macaques, Journal of Virology, vol.76, issue.4, pp.1866-75, 2002.
DOI : 10.1128/JVI.76.4.1866-1875.2002

N. Kadowaki and S. Antonenko, Natural Interferon ??/?????Producing Cells Link Innate and Adaptive Immunity, The Journal of Experimental Medicine, vol.157, issue.2, pp.219-245, 2000.
DOI : 10.1146/annurev.iy.12.040194.005015

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193254/pdf

N. Kadowaki and S. Ho, Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens, The Journal of Experimental Medicine, vol.161, issue.6, pp.863-872, 2001.
DOI : 10.4049/jimmunol.166.1.249

H. Kanzler and F. J. Barrat, Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists, Nature Medicine, vol.26, issue.5, pp.552-561, 2007.
DOI : 10.1038/nm1589

M. L. Kapsenberg, Dendritic-cell control of pathogen-driven T-cell polarization, Nature Reviews Immunology, vol.3, issue.12, pp.984-93, 2003.
DOI : 10.1038/nri1246

H. Karsunky and M. Merad, Developmental origin of interferon-?????producing dendritic cells from hematopoietic precursors, Experimental Hematology, vol.33, issue.2, pp.173-81, 2005.
DOI : 10.1016/j.exphem.2004.10.010

B. L. Kelsall and W. Strober, Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch, Journal of Experimental Medicine, vol.183, issue.1, pp.237-284, 1996.
DOI : 10.1084/jem.183.1.237

R. Kennedy and E. Celis, T cells in anti-tumor immune responses, Immunological Reviews, vol.161, issue.1, pp.129-173, 2008.
DOI : 10.1038/nbt1215

T. Korn and E. Bettelli, IL-17 and Th17 Cells, Annual Review of Immunology, vol.27, issue.1, pp.485-517, 2009.
DOI : 10.1146/annurev.immunol.021908.132710

A. Krug and S. Rothenfusser, Identification of CpG oligonucleotide sequences with high induction of IFN-??/?? in plasmacytoid dendritic cells, European Journal of Immunology, vol.150, issue.7, pp.2154-63, 2001.
DOI : 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U

C. Kurts and H. Kosaka, T Cells, The Journal of Experimental Medicine, vol.157, issue.2, pp.239-284, 1997.
DOI : 10.1002/eji.1830230835

M. Kuwana, Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets, Human Immunology, vol.63, issue.12, pp.1156-63, 2002.
DOI : 10.1016/S0198-8859(02)00754-1

N. Labarriere and M. C. Pandolfino, Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunology, Immunotherapy, vol.51, issue.10, pp.532-540, 2002.
DOI : 10.1007/s00262-002-0313-3

P. Langerhans, Ueber die Nerven der menschlichen Haut, Archiv f??r Pathologische Anatomie und Physiologie und f??r Klinische Medicin, vol.44, issue.2-3, pp.325-328, 1868.
DOI : 10.1007/BF01959006

C. L. Langrish and Y. Chen, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, The Journal of Experimental Medicine, vol.71, issue.2, pp.233-273, 2005.
DOI : 10.1038/nri802

J. R. Lee and R. R. Dalton, Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma, Laboratory Investigation, vol.107, issue.10, pp.1457-66, 2003.
DOI : 10.1073/pnas.231606698

C. Lenahan and D. Avigan, Dendritic cell defects in patients with cancer: mechanisms and significance, Breast Cancer Research, vol.27, issue.1, p.101, 2006.
DOI : 10.1097/00002371-200411000-00005

J. P. Leonard and M. L. Sherman, Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production, Blood, vol.90, pp.2541-2549, 1997.

Y. J. Liu, IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors, Annual Review of Immunology, vol.23, issue.1, pp.275-306, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115633

C. Liu and Y. Lou, Plasmacytoid dendritic cells induce NK celldependent, tumor antigen-specific T cell cross-priming and tumor regression in mice, J Clin Invest, vol.118, pp.1165-75, 2008.

Y. J. Liu and V. Soumelis, TSLP: An Epithelial Cell Cytokine that Regulates T Cell Differentiation by Conditioning Dendritic Cell Maturation, Annual Review of Immunology, vol.25, issue.1, pp.193-219, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141718

V. Lombardi and L. Van-overtvelt, Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-??, and IL-17A by Naive CD4+ T Cells, The Journal of Immunology, vol.182, issue.6, pp.3372-3381, 2009.
DOI : 10.4049/jimmunol.0801969

S. Lonial and C. Torre, Regulation of alloimmune responses by dendritic cell subsets, Experimental Hematology, vol.36, issue.10, pp.1309-1326, 2008.
DOI : 10.1016/j.exphem.2008.04.021

S. Majstoravich and J. Zhang, Lymphocyte microvilli are dynamic, actin-dependent structures that do not require Wiskott-Aldrich syndrome protein (WASp) for their morphology, Blood, vol.104, issue.5, pp.1396-1403, 2004.
DOI : 10.1182/blood-2004-02-0437

O. Manches and G. Lui, In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas, Blood, vol.101, issue.3, pp.949-54, 2003.
DOI : 10.1182/blood-2002-02-0469

C. Manegold and D. Gravenor, Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.26, issue.24, pp.3979-86, 2008.
DOI : 10.1200/JCO.2007.12.5807

P. R. Mangan and L. E. Harrington, Transforming growth factor-?? induces development of the TH17 lineage, Nature, vol.183, issue.7090, pp.231-235, 2006.
DOI : 10.1038/nature04754

B. J. Masten and G. K. Olson, Characterization of Myeloid and Plasmacytoid Dendritic Cells in Human Lung, The Journal of Immunology, vol.177, issue.11, pp.7784-93, 2006.
DOI : 10.4049/jimmunol.177.11.7784

P. Mclaughlin and A. J. Grillo-lopez, Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program., Journal of Clinical Oncology, vol.16, issue.8, pp.2825-2858, 1998.
DOI : 10.1200/JCO.1998.16.8.2825

A. S. Mcwilliam and D. J. Nelson, The biology of airway dendritic cells, Immunology and Cell Biology, vol.151, issue.5, pp.405-418, 1995.
DOI : 10.1038/icb.1995.63

A. L. Mellor and D. H. Munn, Ido expression by dendritic cells: tolerance and tryptophan catabolism, Nature Reviews Immunology, vol.467, issue.10, pp.762-74, 2004.
DOI : 10.1016/S0041-1345(00)02792-5

M. Merad and M. G. Manz, Dendritic cell homeostasis, Blood, vol.113, issue.15, pp.3418-3445, 2009.
DOI : 10.1182/blood-2008-12-180646

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668851

B. G. Molenkamp and P. A. Van-leeuwen, Intradermal CpG-B Activates Both Plasmacytoid and Myeloid Dendritic Cells in the Sentinel Lymph Node of Melanoma Patients, Clinical Cancer Research, vol.13, issue.10, pp.2961-2970, 2007.
DOI : 10.1158/1078-0432.CCR-07-0050

M. C. Montoya and D. Sancho, Cell adhesion and polarity during immune interactions, Immunological Reviews, vol.273, issue.1, pp.68-82, 2002.
DOI : 10.1146/annurev.immunol.12.1.735

D. A. Morgan and F. W. Ruscetti, Selective in vitro growth of T lymphocytes from normal human bone marrows, Science, vol.193, issue.4257, pp.1007-1015, 1976.
DOI : 10.1126/science.181845

D. Morton and F. R. Eilber, Immunological factors which influence response to immunotherapy in malignant melanoma, Surgery, vol.68, pp.158-63, 1970.

E. A. Moseman and X. Liang, Human Plasmacytoid Dendritic Cells Activated by CpG Oligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells, The Journal of Immunology, vol.173, issue.7, pp.4433-4475, 2004.
DOI : 10.4049/jimmunol.173.7.4433

T. R. Mosmann and R. L. Coffman, TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties, Annual Review of Immunology, vol.7, issue.1, pp.145-73, 1989.
DOI : 10.1146/annurev.iy.07.040189.001045

G. E. Mullen and R. D. Ellis, Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria, PLoS ONE, vol.22, issue.8, p.2940, 2008.
DOI : 10.1371/journal.pone.0002940.s002

D. H. Munn and M. D. Sharma, Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes, Journal of Clinical Investigation, vol.114, issue.2, pp.280-90, 2004.
DOI : 10.1172/JCI200421583

K. M. Murphy and S. L. Reiner, Decision making in the immune system: The lineage decisions of helper T cells, Nature Reviews Immunology, vol.17, issue.12, pp.933-977, 2002.
DOI : 10.1038/nri954

N. Novak and C. F. Yu, Toll-like receptor 7 agonists and skin, Drug News Perspect, vol.21, pp.158-65, 2008.

O. Doherty, U. Peng, and M. , Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature, Immunology, vol.82, pp.487-93, 1994.

F. Pagès and A. Kirilovsky, In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-51, 2009.
DOI : 10.1200/JCO.2008.19.6147

D. R. Parkinson and J. S. Abrams, Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study., Journal of Clinical Oncology, vol.8, issue.10, pp.1650-1656, 1990.
DOI : 10.1200/JCO.1990.8.10.1650

M. Pashenkov and G. Goess, Phase II Trial of a Toll-Like Receptor 9???Activating Oligonucleotide in Patients With Metastatic Melanoma, Journal of Clinical Oncology, vol.24, issue.36, pp.5716-5740, 2006.
DOI : 10.1200/JCO.2006.07.9129

A. Pinzon-charry and C. S. Ho, Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer, British Journal of Cancer, vol.25, issue.9, pp.1251-1260, 2007.
DOI : 10.1007/s002620050438

A. Poltorak and X. He, Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene, Science, vol.282, issue.5396, pp.2085-2093, 1998.
DOI : 10.1126/science.282.5396.2085

P. F. Robbins and R. A. Morgan, Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1, Journal of Clinical Oncology, vol.29, issue.7, pp.917-924, 2010.
DOI : 10.1200/JCO.2010.32.2537

M. J. Robertson and C. Cameron, Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer, Clin Cancer Res, vol.5, pp.9-16, 1999.

W. A. Robinson and T. I. Mughal, Treatment of Metastatic Malignant Melanoma with Recombinant Interferon Alpha 2, Immunobiology, vol.172, issue.3-5, pp.275-82, 1986.
DOI : 10.1016/S0171-2985(86)80109-7

K. L. Rock and S. Gamble, Presentation of exogenous antigen with class I major histocompatibility complex molecules, Science, vol.249, issue.4971, pp.918-939, 1990.
DOI : 10.1126/science.2392683

A. Rodriguez and A. Regnault, Selective transport of internalized antigens to the cytosol for HMC class I presentation in dendritic cells, Nat Cell Biol, vol.1, pp.362-370, 1999.

S. A. Rosenberg and M. T. Lotze, Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients, Annals of Surgery, vol.210, issue.4, pp.474-84, 1989.
DOI : 10.1097/00000658-198910000-00008

S. Sakaguchi, Regulatory T Cells, Cell, vol.101, issue.5, pp.455-463, 2000.
DOI : 10.1016/S0092-8674(00)80856-9

URL : https://hal.archives-ouvertes.fr/hal-01358192

M. Salio and M. Cella, Plasmacytoid dendritic cells prime IFN-??-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions, European Journal of Immunology, vol.33, issue.4, pp.1052-62, 2003.
DOI : 10.1002/eji.200323676

M. P. Schon and M. Schon, TLR7 and TLR8 as targets in cancer therapy, Oncogene, vol.14, issue.2, pp.190-199, 2008.
DOI : 10.1016/j.vaccine.2003.10.051

G. Schreibelt and J. Tel, Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy, Cancer Immunology, Immunotherapy, vol.42, issue.10, pp.1573-1582, 2010.
DOI : 10.1007/s00262-010-0833-1

H. J. Schulze and B. Cribier, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe, British Journal of Dermatology, vol.95, issue.5, pp.939-986, 2005.
DOI : 10.1111/j.0022-202X.2004.22528.x

O. Schwartz, Cell of the month: A dendritic cell sensing a lymphocyte, Nature Cell Biology, vol.6, issue.3, p.175, 2004.
DOI : 10.1038/ncb0304-188

M. D. Sharma and B. Baban, Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase, Journal of Clinical Investigation, vol.117, issue.9, pp.2570-82, 2007.
DOI : 10.1172/JCI31911DS1

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940240

H. Shigematsu and B. Reizis, Plasmacytoid Dendritic Cells Activate Lymphoid-Specific Genetic Programs Irrespective of Their Cellular Origin, Immunity, vol.21, issue.1, pp.43-53, 2004.
DOI : 10.1016/j.immuni.2004.06.011

F. P. Siegal and N. Kadowaki, The Nature of the Principal Type 1&nbsp;Interferon-Producing Cells in Human Blood, Science, vol.284, issue.5421, pp.1835-1842, 1999.
DOI : 10.1126/science.284.5421.1835

L. J. Sigal and S. Crotty, Cytotoxic T-cell immunity to virus-infected nonhaematopoietic cells requires presentation of exogenous antigen, Nature, vol.398, pp.77-80, 1999.

D. J. Slamon and B. Leyland-jones, Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2, New England Journal of Medicine, vol.344, issue.11, pp.783-92, 2001.
DOI : 10.1056/NEJM200103153441101

R. V. Sorg and G. Kogler, Identification of cord blood dendritic cells as an immature CD11c-population, Blood, vol.93, pp.2302-2309, 1999.

D. E. Speiser and D. Liénard, Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909, Journal of Clinical Investigation, vol.115, issue.3, pp.739-785, 2005.
DOI : 10.1172/JCI23373

G. Stary and C. Bangert, Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells, The Journal of Experimental Medicine, vol.52, issue.6, pp.1441-51, 2007.
DOI : 10.1016/0022-1759(96)00063-4

B. Steiniger and J. Klempnauer, PHENOTYPE AND HISTOLOGICAL DISTRIBUTION OF INTERSTITIAL DENDRITIC CELLS IN THE RAT PANCREAS, LIVER, HEART, AND KIDNEY, Transplantation, vol.38, issue.2, pp.169-74, 1984.
DOI : 10.1097/00007890-198408000-00016

R. M. Steinman, The Dendritic Cell System and its Role in Immunogenicity, Annual Review of Immunology, vol.9, issue.1, pp.271-96, 1991.
DOI : 10.1146/annurev.iy.09.040191.001415

R. M. Steinman and Z. A. Cohn, IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE: I. MORPHOLOGY, QUANTITATION, TISSUE DISTRIBUTION, Journal of Experimental Medicine, vol.137, issue.5, pp.1142-62, 1973.
DOI : 10.1084/jem.137.5.1142

K. Takeda, S. Akira, . Tlr, and . Pathways, TLR signaling pathways, Seminars in Immunology, vol.16, issue.1, pp.3-9, 2004.
DOI : 10.1016/j.smim.2003.10.003

A. W. Thomson, Tolerogenic Dendritic Cells: All Present and Correct?, American Journal of Transplantation, vol.20, issue.Suppl 2, pp.214-219, 2010.
DOI : 10.1111/j.1600-6143.2009.02955.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860031

A. W. Thomson and M. L. Drakes, Hepatic dendritic cells: immunobiology and role in liver transplantation, J Leukoc Biol, vol.66, pp.322-352, 1999.

I. Treilleux and J. Y. Blay, Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer, Clinical Cancer Research, vol.10, issue.22, pp.7466-74, 2004.
DOI : 10.1158/1078-0432.CCR-04-0684

G. Trinchieri, Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nature Reviews Immunology, vol.3, issue.2, pp.133-179, 2003.
DOI : 10.1038/nri1001

P. Van-der-bruggen and C. Traversi, A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, vol.254, issue.5038, pp.1643-1650, 1991.
DOI : 10.1126/science.1840703

W. Vermi and R. Bonecchi, Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas, The Journal of Pathology, vol.74, issue.2, pp.255-68, 2003.
DOI : 10.1002/path.1344

D. Vremec and J. Pooley, CD4 and CD8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen, The Journal of Immunology, vol.164, issue.6, pp.2978-86, 2000.
DOI : 10.4049/jimmunol.164.6.2978

J. Wenzel and B. Bekisch, Type I Interferon???Associated Recruitment of Cytotoxic Lymphocytes, American Journal of Clinical Pathology, vol.124, issue.1, pp.37-48, 2005.
DOI : 10.1309/4EJ9KL7CGDENVVLE

N. J. Wilson and K. Boniface, Development, cytokine profile and function of human interleukin 17???producing helper T cells, Nature Immunology, vol.176, issue.9, pp.950-957, 2007.
DOI : 10.1084/jem.194.4.519

I. H. Wolf and K. Kodama, Nature of Inflammatory Infiltrate in Superficial Cutaneous Malignancies During Topical Imiquimod Treatment, The American Journal of Dermatopathology, vol.29, issue.3, pp.237-278, 2007.
DOI : 10.1097/01.dad.0000211531.33670.94

C. J. Workman and A. L. Szymczak-workman, The development and function of regulatory T cells, Cellular and Molecular Life Sciences, vol.204, issue.16, pp.2603-2605, 2009.
DOI : 10.1007/s00018-009-0026-2

J. Xing and Y. Wu, Th9: A New Player in Asthma Pathogenesis?, Journal of Asthma, vol.183, issue.61, pp.115-140, 2011.
DOI : 10.1182/blood.V97.4.1035

C. Yee and J. A. Thompson, Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells, Proceedings of the National Academy of Sciences, vol.99, issue.25, pp.16168-73, 2002.
DOI : 10.1073/pnas.242600099

N. Zhang and H. F. Pan, Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention, Molecular and Cellular Biochemistry, vol.1, issue.1, 2011.
DOI : 10.1007/s11010-011-0772-y

W. Zou, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nature Reviews Cancer, vol.1, issue.4, pp.263-74, 2005.
DOI : 10.1073/pnas.96.26.15074

W. Zou and V. Machelon, Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nature Medicine, vol.7, issue.12, pp.1339-1385, 2001.
DOI : 10.1038/nm1201-1339